The role of cerebrospinal fluid and other biomarker modalities in the Alzheimer's disease diagnostic revolution

被引：21
|
作者：
Schindler, Suzanne E. [1 ,2 ]
Atri, Alireza [3 ,4 ,5 ]
机构：
[1] Washington Univ St Louis, Dept Neurol, St Louis, MO 63130 USA
[2] Charles F & Joanne Knight Alzheimer Dis Res Ctr, St Louis, MO 63130 USA
[3] Banner Hlth, Banner Sun Hlth Res Inst, Sun City, AZ USA
[4] Brigham & Womens Hosp, Ctr Brain Mind Med, Dept Neurol, Boston, MA USA
[5] Harvard Med Sch, Boston, MA USA
来源：
NATURE AGING | 2023年 / 3卷 / 05期
关键词：
TAU;
D O I：
10.1038/s43587-023-00400-6
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
A major transformation in dementia diagnosis and care appears imminent and will depend on three major types of biomarkers: molecular imaging, blood-based biomarkers and cerebrospinal fluid biomarkers. Each modality has unique strengths and limitations that suggest its optimal uses in research, clinical trials and clinical diagnosis.
引用
收藏
页码：460 / 462
页数：3
相关论文
共 50 条
  • [41] SCRN1: A cerebrospinal fluid biomarker correlating with tau in Alzheimer's disease
    Weiner, Sophia
    Sauer, Mathias
    Brinkmalm, Gunnar
    Constantinescu, Julius
    Constantinescu, Radu
    Gomes, Barbara Fernandes
    Becker, Bruno
    Nellgard, Bengt
    Dalla, Keti
    Galasko, Douglas
    Zetterberg, Henrik
    Blennow, Kaj
    Gobom, Johan
    ALZHEIMERS & DEMENTIA, 2023, 19 (10) : 4609 - 4618
  • [42] The cerebrospinal fluid biomarker profile in an HIV-infected subject with Alzheimer's disease
    Makitalo, Signar
    Mellgren, Asa
    Borgh, Ellen
    Kilander, Lena
    Skillback, Tobias
    Zetterberg, Henrik
    Gisslen, Magnus
    AIDS RESEARCH AND THERAPY, 2015, 12
  • [43] Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer's disease
    Aichholzer, Freyja
    Klafki, Hans-Wolfgang
    Ogorek, Isabella
    Vogelgsang, Jonathan
    Wiltfang, Jens
    Scherbaum, Norbert
    Weggen, Sascha
    Wirths, Oliver
    ALZHEIMERS RESEARCH & THERAPY, 2021, 13 (01)
  • [44] Long-Term Stability of Alzheimer's Disease Biomarker Proteins in Cerebrospinal Fluid
    Schipke, Carola G.
    Jessenb, Frank
    Teipel, Stefan
    Luckhaus, Christian
    Wiltfang, Jens
    Esselmann, Hermann
    Frolich, Lutz
    Maier, Wolfgang
    Ruther, Eckart
    Heppner, Frank L.
    Prokop, Stefan
    Heuser, Isabella
    Peters, Oliver
    JOURNAL OF ALZHEIMERS DISEASE, 2011, 26 (02) : 255 - 262
  • [45] Differential Expression of microRNA in Cerebrospinal Fluid as a Potential Novel Biomarker for Alzheimer's Disease
    van Harten, Argonde C.
    Mulders, Joyce
    Scheltens, Philip
    van der Flier, Wiesje M.
    Oudejans, Cees B. M.
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 47 (01) : 243 - 252
  • [46] Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer’s disease
    Freyja Aichholzer
    Hans-Wolfgang Klafki
    Isabella Ogorek
    Jonathan Vogelgsang
    Jens Wiltfang
    Norbert Scherbaum
    Sascha Weggen
    Oliver Wirths
    Alzheimer's Research & Therapy, 13
  • [47] The cerebrospinal fluid biomarker profile in an HIV-infected subject with Alzheimer’s disease
    Signar Mäkitalo
    Åsa Mellgren
    Ellen Borgh
    Lena Kilander
    Tobias Skillbäck
    Henrik Zetterberg
    Magnus Gisslén
    AIDS Research and Therapy, 12
  • [48] Anti-Correlated Cerebrospinal Fluid Biomarker Trajectories in Preclinical Alzheimer's Disease
    Gomar, Jesus J.
    Conejero-Goldberg, Concepcion
    Davies, Peter
    Goldberg, Terry E.
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 51 (04) : 1085 - 1096
  • [49] Required improvements for cerebrospinal fluid-based biomarker tests of Alzheimer's disease
    Gaetani, Lorenzo
    Chiasserini, Davide
    Paoletti, Federico Paolini
    Bellomo, Giovanni
    Parnetti, Lucilla
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2023, 23 (12) : 1195 - 1207
  • [50] Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
    Palmqvist, Sebastian
    Insel, Philip S.
    Stomrud, Erik
    Janelidze, Shorena
    Zetterberg, Henrik
    Brix, Britta
    Eichenlaub, Udo
    Dage, Jeffrey L.
    Chai, Xiyun
    Blennow, Kaj
    Mattsson, Niklas
    Hansson, Oskar
    EMBO MOLECULAR MEDICINE, 2019, 11 (12)
12345